Kalehua Capital Management LLC
CIK 2106181 · View on SEC EDGAR ↗
- Portfolio value
- $174.0M
- Positions
- 26
- As of
- June 30, 2026
#6,928 of 9,443 by 13F value · top 73.4%
Portfolio value QoQ: +36.9% 13F does not disclose cash
- Top 10 holdings weight
- 70.75%
- Top 25 holdings weight
- 99.74%
- Positions above 1%
- 22
- Effective number of positions
- 14.4
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 19.87% Est. buys $48,373,638 · sells $29,897,279
- New positions
- 8
- Increased
- 4
- Decreased
- 2
- Closed
- 7
On this page
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- Biggest new bets Brand-new positions opened in the latest quarter.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
Sector breakdown
Healthcare
82.7%
Other/Unmapped
17.3%
Full portfolio 26 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| BOXX | $26,484,353 | 15.22% | 226,188 | $12,713,059 | Up ×1 | ||
| MANE Veradermics, Incorporated Common Stock | $17,911,743 | 10.30% | 145,695 | $11,414,934 | Up ×1 | ||
| XFOR X4 Pharmaceuticals, Inc. - Common Stock | $17,385,663 | 9.99% | 3,722,840 | $2,010,334 | |||
| CMPS COMPASS Pathways Plc - American Depository Shares | $11,598,642 | 6.67% | 819,692 | $7,065,745 | |||
| SRZN Surrozen, Inc. - Common Stock | $9,995,369 | 5.75% | 385,178 | $-1,224,866 | |||
| ACRS Aclaris Therapeutics, Inc. - Common Stock | $9,693,211 | 5.57% | 1,832,365 | $2,821,842 | |||
| SION Sionna Therapeutics, Inc. - Common Stock | $8,669,197 | 4.98% | 197,072 | $768,581 | |||
| IKT Inhibikase Therapeutics, Inc. - Common Stock | $7,758,437 | 4.46% | 3,821,890 | $1,337,662 | |||
| PHVS Pharvaris N.V. - Ordinary Shares | $6,873,536 | 3.95% | 198,772 | $1,258,227 | |||
| KPTI Karyopharm Therapeutics Inc. - Common Stock | $6,698,742 | 3.85% | 685,644 | Up ×1 | |||
| SEPN Septerna, Inc. - Common Stock | $6,515,279 | 3.75% | 194,544 | $1,840,387 | |||
| IFRX InflaRx N.V. - Common Stock | $6,491,003 | 3.73% | 2,897,769 | Up ×1 | |||
| CYCN Cyclerion Therapeutics, Inc. - Common Stock | $5,598,077 | 3.22% | 1,651,350 | Up ×1 | |||
| KRRO Korro Bio, Inc. - Common Stock | $5,338,427 | 3.07% | 405,040 | $4,100,291 | Up ×1 | ||
| QURE uniQure N.V. - Ordinary Shares | $3,657,486 | 2.10% | 79,407 | $-1,102,146 | Down ×1 | ||
| LONA LeonaBio, Inc. - Common Stock | $3,618,112 | 2.08% | 393,701 | $-429,134 | |||
| GLTO Galecto, Inc. - Common Stock | $3,615,390 | 2.08% | 139,000 | $15,290 | |||
| MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | $3,421,541 | 1.97% | 175,734 | $145,859 | |||
| ANL Adlai Nortye Ltd. - American Depositary Shares | $2,603,773 | 1.50% | 226,415 | Up ×1 | |||
| TYRA Tyra Biosciences, Inc. - Common Stock | $2,378,412 | 1.37% | 74,465 | $-473,597 | |||
| NVCT Nuvectis Pharma, Inc. - Common Stock | $1,839,000 | 1.06% | 100,000 | Up ×1 | |||
| GOSS Gossamer Bio, Inc. - Common Stock | $1,835,185 | 1.05% | 11,149,363 | $-1,527,437 | Up ×1 | ||
| MIST Milestone Pharmaceuticals Inc. - Common Shares | $1,700,778 | 0.98% | 1,269,237 | Up ×1 | |||
| ATYR aTyr Pharma, Inc. - Common Stock | $1,067,178 | 0.61% | 1,788,167 | Up ×1 | |||
| TIL Instil Bio, Inc. - Common Stock | $765,924 | 0.44% | 99,600 | $-742,243 | Down ×1 | ||
| TCRX TScan Therapeutics, Inc. - Common Stock | $445,824 | 0.26% | 454,876 | Up ×1 | |||
| No matches | |||||||
Biggest new bets
New positions opened this quarter, largest first.
Top movers (QoQ)
| Security | Action | Shares Δ | Value Δ |
|---|---|---|---|
| BOXX | Bought more | +108K | +$12.7M |
| MANE | Bought more | +43K | +$11.4M |
| CMPS | Price move only | +0 | +$7.1M |
| KRRO | Bought more | +296K | +$4.1M |
| ACRS | Price move only | +0 | +$2.8M |
| XFOR | Price move only | +0 | +$2.0M |
| SEPN | Price move only | +0 | +$1.8M |
| GOSS | Bought more | +913K | -$1.5M |
| IKT | Price move only | +0 | +$1.3M |
| PHVS | Price move only | +0 | +$1.3M |
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| RLAY | June 30, 2026 | 901,457 | $8,969,497 | 7.2% |
| ORKA | June 30, 2026 | 118,524 | $5,813,602 | 12.4% |
| ALLO | March 31, 2026 | 2,546,129 | $3,488,197 | -13.3% |
| ORIC | March 31, 2026 | 267,059 | $2,184,543 | 10.8% |
| VRCA | March 31, 2026 | 235,779 | $1,959,323 | -5.7% |
| PEPG | June 30, 2026 | 1,000,000 | $1,770,000 | 74.4% |
| TNYA | June 30, 2026 | 2,000,000 | $1,384,800 | -4.6% |
| KLRS | June 30, 2026 | 135,585 | $782,325 | 0.7% |
| DMAC | June 30, 2026 | 62,488 | $423,044 | -7.1% |
| LOOP | June 30, 2026 | 347,539 | $361,441 | -37.9% |